Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2024EN)}} ==General information== Name: '''nl.zorg.Hypersensitivity''' link=Overgevoeligheid-v1.0(2024NL)
Version: '''1.0'''
HCIM Status:Final
Release: '''2024'''...'

2024-06-26T15:03:35Z

Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2024EN)}}  ==General information== Name: '''nl.zorg.Hypersensitivity''' link=Overgevoeligheid-v1.0(2024NL) Version: '''1.0''' HCIM Status:Final Release: '''2024'''...'

Nieuwe pagina

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2024EN)}}

==General information==
Name: '''nl.zorg.Hypersensitivity''' [[Bestand:NL.png|link=Overgevoeligheid-v1.0(2024NL)]] 
Version: '''1.0''' 
HCIM Status:Final 
Release: '''2024''' 
Release status: Prepublished 
Release date: 15-04-2024

{{ErrataEN|2024|{{PAGENAME}}}}

-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2024(EN)]] [[HCIM_Release_2024(EN) |Back to HCIM list ]]</div>

==Metadata==
{| class="wikitable" style="font-size:90%; width: 750px"
|-
|style="width:250px; "|DCM::CoderList||Werkgroep Overgevoeligheid
|-
|style="width:250px; "|DCM::ContactInformation.Address||*
|-
|style="width:250px; "|DCM::ContactInformation.Name||*
|-
|style="width:250px; "|DCM::ContactInformation.Telecom||*
|-
|style="width:250px; "|DCM::ContentAuthorList||Werkgroep Overgevoeligheid
|-
|style="width:250px; "|DCM::CreationDate||4-10-2021
|-
|style="width:250px; "|DCM::DeprecatedDate||
|-
|style="width:250px; "|DCM::DescriptionLanguage||nl
|-
|style="width:250px; "|DCM::EndorsingAuthority.Address||
|-
|style="width:250px; "|DCM::EndorsingAuthority.Name||PM
|-
|style="width:250px; "|DCM::EndorsingAuthority.Telecom||
|-
|style="width:250px; "|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.8.4
|-
|style="width:250px; "|DCM::KeywordList||Allergie,Overgevoeligheid
|-
|style="width:250px; "|DCM::LifecycleStatus||Final
|-
|style="width:250px; "|DCM::ModelerList||Werkgroep Overgevoeligheid
|-
|style="width:250px; "|DCM::Name||nl.zorg.Overgevoeligheid
|-
|style="width:250px; "|DCM::PublicationDate||15-04-2024
|-
|style="width:250px; "|DCM::PublicationStatus||Prepublished
|-
|style="width:250px; "|DCM::ReviewerList||Werkgroep Overgevoeligheid
|-
|style="width:250px; "|DCM::RevisionDate||
|-
|style="width:250px; "|DCM::Supersedes||
|-
|style="width:250px; "|DCM::Version||1.0
|-
|style="width:250px; "|HCIM::PublicationLanguage||EN
|}

==Revision History==
<div class="mw-collapsible mw-collapsed">
'' Only available in Dutch''

Publicatieversie 1.0 (01-12-2021)
.
</div>

==Concept==
A hypersensitivity describes a substance or group of substances that is monitored so that a hypersensitivity reaction can be prevented.

==Purpose==
<ul>
<li id=c129>A drug hypersensitivity is recorded so that prescribers, providers and administrators can take it into account when prescribing, dispensing and administering medication. It is recorded in such a way that a medication monitoring system can give a warning at the right time. Other sensitivities such as food, contact, inhalation, insect venom and occupational allergens are recorded so that healthcare providers can take them into account in a general sense. 
<li>It is important to share sensitivities with other caregivers of the patient so that they too can provide care in a safe manner. For that purpose, it is possible to record and exchange additional information so that the receiving party can appreciate the hypersensitivity. For example, by describing the method of determination, and also a description of (a) reaction(s) to the substance. 
<li>A (drug) hypersensitivity is not the same as a problem or episode. That's because a hypersensitivity is captured specifically from the context of surveillance. A (drug) hypersensitivity is therefore not recorded in the context of diagnostics or in the context of treatment of a (drug) hypersensitivity. </li></ul>

==Evidence Base==
<ul>
<li>In order to be able to register and handle hypersensitivities in the work process of prescribers and pharmacists (in pharmacovigilance), the available codings in the G-standard and SHB are used for medicines in the Netherlands. The working method is laid down in the agreement set Registration and transfer of drug hypersensitivities. 
<li>For hypersensitivity to food, articles (such as bandages and plasters), plants and animals, five reference lists based on SNOMED CT containing food allergens, inhalation allergens, insect venom allergens, occupational allergens and contact allergens are used. Free text is also possible. </li></ul>

==Information Model==
 
<imagemap> Bestand:Hypersensitivity-v1.0Model(2024EN).png | center
rect 683 255 773 325 [[Reaction-v2.0(2024EN)]]
rect 670 338 786 407 [[HealthProfessional-v4.0(2024EN)]]
rect 852 436 997 486 [[#WayOfDeterminationCodelist]]
rect 670 515 786 585 [[#2357]]
rect 670 425 786 495 [[#2350]]
rect 670 160 786 228 [[#2329]]
rect 531 156 621 226 [[#2351]]
rect 298 707 536 745 [[#AgentHPKCodelist]]
rect 318 658 564 696 [[#AgentAllergicAgentCodelist]]
rect 60 707 294 745 [[#AgentThesaurus122Codelist]]
rect 35 608 238 646 [[#AgentSNKCodelist]]
rect 50 659 261 697 [[#AgentSSKCodelist]]
rect 374 154 486 224 [[#2349]]
rect 224 156 354 226 [[#2347]]
rect 224 336 354 406 [[#2363]]
rect 416 608 575 646 [[#HypersensitivityStatusCodelist]]
rect 37 441 210 479 [[#HypersensitivityCategoryCodelist]]
rect 37 354 196 392 [[#CriticalExtentCodelist]]
rect 431 515 543 585 [[#2356]]
rect 224 426 354 496 [[#2361]]
rect 224 515 354 585 [[#2360]]
rect 225 246 355 316 [[#2359]]
rect 432 309 542 379 [[#2348]]
desc none
</imagemap>
 
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:8.4.1
|colspan ="6" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px | link=]]Hypersensitivity
|
|Root concept of the Hypersensitivity information model. This root concept contains all data elements of the Hypersensitivity information model.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:8.4.2
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Reaction
|0..*
|Root concept of the Reaction information model. This root concept contains all data elements of the Reaction information model.
|
|
{|
|-
|[[Bestand: block.png | link=Reaction-v2.0(2024EN)]]||[[Reaction-v2.0(2024EN) |Reaction]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:8.4.3
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]DateTimeClosure
|0..1
|The date and time when it was decided to stop monitoring.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:8.4.4
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]FirstAuthor::HealthProfessional
|1
|The healthcare professional who first started monitoring the hypersensitivity.
|
|
{|
|-
|[[Bestand: block.png | link=HealthProfessional-v4.0(2024EN)]]||[[HealthProfessional-v4.0(2024EN) |HealthProfessional]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:8.4.5
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]WayOfDetermination
|0..1
|The way in which the hypersensitivity is determined.
|
|
{|
|-
|[[Bestand: List2.png | link=#WayOfDeterminationCodelist]]||[[#WayOfDeterminationCodelist|WayOfDeterminationCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:8.4.6
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]SourceDescription
|0..1
|The description of how the information was obtained, such as receiving a letter from a specialist or an interview with the patient.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:8.4.7
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]ReasonForClosure
|0..1
|Reason why the hypersensitivity is closed.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:8.4.8
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Agent
|1
|The substance or group of substances that is monitored.
|
|
{|
|-
|[[Bestand: List2.png | link=#AgentAllergicAgentCodelist]]||[[#AgentAllergicAgentCodelist|AgentAllergicAgentCodelist]]
|-
|[[Bestand: List2.png | link=#AgentHPKCodelist]]||[[#AgentHPKCodelist|AgentHPKCodelist]]
|-
|[[Bestand: List2.png | link=#AgentSNKCodelist]]||[[#AgentSNKCodelist|AgentSNKCodelist]]
|-
|[[Bestand: List2.png | link=#AgentSSKCodelist]]||[[#AgentSSKCodelist|AgentSSKCodelist]]
|-
|[[Bestand: List2.png | link=#AgentThesaurus122Codelist]]||[[#AgentThesaurus122Codelist|AgentThesaurus122Codelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:8.4.9
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]HypersensitivityCategory
|0..*
|Identifies the hypersensitivity category such as medication, food or environment.
|
|
{|
|-
|[[Bestand: List2.png | link=#HypersensitivityCategoryCodelist]]||[[#HypersensitivityCategoryCodelist|HypersensitivityCategoryCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:8.4.10
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]HypersensitivityStatus
|0..1
|Statement on the status of the patient’s hypersensitivity.
|
|
{|
|-
|[[Bestand: List2.png | link=#HypersensitivityStatusCodelist]]||[[#HypersensitivityStatusCodelist|HypersensitivityStatusCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:8.4.11
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]StartDateTime
|0..1
|Date and time when the hypersensitivity first manifested itself in a reaction. This can be an exact date and time, but also a global indication of the date (for example, only year or year and month).

|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:8.4.12
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Criticality
|1
|The healthcare professional's assessment of whether the hypersensitivity is a contraindication to intended or unintended exposure to the substance, group of substances or environmental factor to which the patient is hypersensitive.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=246112005 246112005] Severity
|}
|
{|
|-
|[[Bestand: List2.png | link=#CriticalExtentCodelist]]||[[#CriticalExtentCodelist|CriticalExtentCodelist]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:8.4.13
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]StartSurveillanceDateTime
|1
|Date and time when the first author started monitoring the hypersensitivity.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:8.4.14
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Comment
|0..1
|Textual explanation of the hypersensitivity which cannot be entered in any of the other fields.
|
{|
|-
|[https://terminologie.nictiz.nl/art-decor/loinc?conceptId=48767-8 48767-8] Annotation comment [Interpretation] Narrative
|}
|
|}
Columns Concept and DefinitionCode: hover over the values for more information 
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]

==Example Instances==
''Only available in Dutch''

{|class="wikitable" width="759px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
|colspan="3" style="background-color: #004080; width: 100%; "|Overgevoeligheid
|-style=vertical-align:top;
| style="width: 30%; "|Stof 
| style="width: 27%; "|Amoxicilline/clavulaanzuur
| style="width: 43%; "|Penicillines
|-style=vertical-align:top;
| style="width: 30%; "|Overgevoeligheidscategorie
| style="width: 27%; "|Geneesmiddelen
| style="width: 43%; "|Geneesmiddelen
|-style=vertical-align:top;
|colspan="3" style="background-color: #4F81BD; width: 100%; "|EersteAuteur::Zorgverlener
|-style=vertical-align:top;
| style="width: 30%; "|Naam
| style="width: 27%; "|Mevr. Zaal
| style="width: 43%; "|Mevr. Zaal
|-style=vertical-align:top;
| style="width: 30%; "|Specialisme
| style="width: 27%; "|SEH-arts
| style="width: 43%; "|SEH-arts
|-style=vertical-align:top;
|colspan="3" style="background-color: #2E74B5; width: 100%; "|
|-style=vertical-align:top;
| style="width: 30%; "|Risicobeoordeling 
| style="width: 27%; "|Laag
| style="width: 43%; "|Ernstig
|-style=vertical-align:top;
| style="width: 30%; "|Manier van vast stellen
| style="width: 27%; "|Vastgesteld op basis van het klinisch beeld
| style="width: 43%; "|Op basis van anamnese
|-style=vertical-align:top;
| style="width: 30%; "|Omschrijving van de bron
| style="width: 27%; "|Gesprek met patiënt
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|Toelichting
| style="width: 27%; "|<noWiki>-</noWiki>
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|Begindatumtijd
| style="width: 27%; "|25-10-2021
| style="width: 43%; "|25-10-2021
|-style=vertical-align:top;
| style="width: 30%; "|Startbewakingdatumtijd
| style="width: 27%; "|25-10-2021
| style="width: 43%; "|25-10-2021
|-style=vertical-align:top;
| style="width: 30%; "|Datum van afsluiten
| style="width: 27%; "|<noWiki>-</noWiki>
| style="width: 43%; "|<noWiki>-</noWiki>
|-style=vertical-align:top;
| style="width: 30%; "|Overgevoeligheidstatus
| style="width: 27%; "|Actief
| style="width: 43%; "|Actief
|-style=vertical-align:top;
|colspan="3" style="background-color: #4F81BD; width: 100%; "|Reactie
|-style=vertical-align:top;
| style="width: 30%; "|ReactieErnst
| style="width: 27%; "|Ernstig
| style="width: 43%; "|Matig
|-style=vertical-align:top;
| style="width: 30%; "|ReactieTijdstip
| style="width: 27%; "|12-10-2020
| style="width: 43%; "|02-06-2021
|-style=vertical-align:top;
| style="width: 30%; "|ReactieSymptomen
| style="width: 27%; "|Trombocytopenie
| style="width: 43%; "|Jeuk
|-style=vertical-align:top;
| style="width: 30%; "|Veroorzakendestof
| style="width: 27%; "|Amoxicilline/clavulaanzuur
| style="width: 43%; "|Penicillines
|-style=vertical-align:top;
| style="width: 30%; "|
| style="width: 27%; "|
| style="width: 43%; "|
|}

==Issues==
No known allergies
The question is whether to offer a code for "No known allergies (SNOMED CT 160244002)" and subdirectories in this information model that fall under this code, or to determine that, where applicable, the document should outline when the information model is to be applied. 

Value set for the ‘Causative substance’ concept 
Currently, no defined code list is yet available for allergenic substances other than medication. Entering SNOMED CT must therefore suffice to code allergenic substances for the time-being. The G standard is used to code medical products. 

==References==
1. Z-INDEX. (2011) Allergieën en ongewenste middelen [Online] v. R V-2-3-1 Beschikbaar op: http://www.z-index.nl/g-standaard/beschrijvingen/functioneel/wijzigingen/mb/bewaking-op-allergie/IR%20Allergieen%20V%202-1-1.pdf [Geraadpleegd: 15 oktober 2014]

2. HL7 FHIR Resource AllergyIntolerance. [Online] Continuous Build. Beschikbaar op: http://hl7-fhir.github.io/allergyintolerance.html [Geraadpleegd: 12 maart 2014]

== Valuesets ==
=== AgentAllergicAgentCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.2
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Codesystem name||Codesystem OID
|-style="vertical-align:top; "
|SNOMED CT: ^[https://terminologie.nictiz.nl/terminology/snomed/viewRefset?id=98061000146100 98061000146100]<noWiki>|</noWiki>Dutch total non-drug allergen simple reference set<noWiki>|</noWiki>
|SNOMED CT
|2.16.840.1.113883.6.96
|}
=== AgentHPKCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.3
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Codesystem name||Codesystem OID
|-style="vertical-align:top; "
|All values
|G-Standaard Handels Product Kode (HPK)
|2.16.840.1.113883.2.4.4.7
|}
=== AgentSNKCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.4
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Codesystem name||Codesystem OID
|-style="vertical-align:top; "
|All values
|G-standaard Stofnaamcode (SNK)
|2.16.840.1.113883.2.4.4.1.750
|}
=== AgentSSKCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.5
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Codesystem name||Codesystem OID
|-style="vertical-align:top; "
|All values
|G-standaard Stofnaamcode i.c.m. toedieningsweg (SSK)
|2.16.840.1.113883.2.4.4.1.725
|}
=== AgentThesaurus122Codelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.6
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Codesystem name||Codesystem OID
|-style="vertical-align:top; "
|All values
|G-standaard Ongewenste medicatiegroepen
|2.16.840.1.113883.2.4.4.1.902.122
|}
=== CriticalExtentCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.9
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Mild
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=255604002 255604002]
|SNOMED CT
|2.16.840.1.113883.6.96
|Laag
|-style="vertical-align:top; "
|Severe
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=24484000 24484000]
|SNOMED CT
|2.16.840.1.113883.6.96
|Hoog
|-style="vertical-align:top; "
|Geen oordeel
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=NTB NTB]
|SNOMED CT
|2.16.840.1.113883.6.96
|Geen oordeel
|}
=== HypersensitivityCategoryCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.7
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Propensity to adverse reactions to food
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=418471000 418471000]
|SNOMED CT
|2.16.840.1.113883.6.96
|Voedselallergeen
|-style="vertical-align:top; "
|Propensity to adverse reactions to drug
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=419511003 419511003]
|SNOMED CT
|2.16.840.1.113883.6.96
|Geneesmiddel
|-style="vertical-align:top; "
|Propensity to adverse reaction to occupational allergen
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=157541000146109 157541000146109]
|SNOMED CT
|2.16.840.1.113883.6.96
|Beroepsallergeen
|-style="vertical-align:top; "
|Propensity to adverse reaction to inhalation allergen
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=157521000146103 157521000146103]
|SNOMED CT
|2.16.840.1.113883.6.96
|Inhalatieallergeen
|-style="vertical-align:top; "
|Propensity to adverse reaction to contact allergen
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=157531000146101 157531000146101]
|SNOMED CT
|2.16.840.1.113883.6.96
|Contactallergeen
|-style="vertical-align:top; "
|Propensity to adverse reaction to insect venom
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=157511000146108 157511000146108]
|SNOMED CT
|2.16.840.1.113883.6.96
|Insectengifallergeen
|}
=== HypersensitivityStatusCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.8
|Binding: Required
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Active
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=55561003 55561003]
|SNOMED CT
|2.16.840.1.113883.6.96
|Actief
|-style="vertical-align:top; "
|Inactive
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=73425007 73425007]
|SNOMED CT
|2.16.840.1.113883.6.96
|Inactief
|}
=== WayOfDeterminationCodelist===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID: 2.16.840.1.113883.2.4.3.11.60.40.2.8.4.1
|Binding: Extensible
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Vastgesteld op basis van het klinisch beeld en aanvullend onderzoek
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=NTB NTB]
|SNOMED CT
|2.16.840.1.113883.6.96
|Vastgesteld op basis van het klinisch beeld en aanvullend onderzoek
|-style="vertical-align:top; "
|Vastgesteld op basis van het klinisch beeld
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=NTB NTB]
|SNOMED CT
|2.16.840.1.113883.6.96
|Vastgesteld op basis van het klinisch beeld
|-style="vertical-align:top; "
|Op basis van de anamnese
|[https://terminologie.nictiz.nl/art-decor/snomed-ct?conceptId=NTB NTB]
|SNOMED CT
|2.16.840.1.113883.6.96
|Op basis van de anamnese
|}

==This information model in other releases==

{{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|2|2024}}

==Information model references==
====This information model refers to====
*[[HealthProfessional-v4.0(2024EN)|HealthProfessional-v4.0]]
*[[Reaction-v2.0(2024EN)|Reaction-v2.0]]
====This information model is used in====
*[[Exclusion-v1.0(2024EN)|Exclusion-v1.0]]
==Technical specifications in HL7v3 CDA and HL7 FHIR==
To exchange information based on health and care information models, additional, more technical specifications are required. 
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment {{ArtDecorLinks|2024|8.4}}</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR {{SimplefierLinks|2024|Overgevoeligheid}}</li>
</ul>
==Downloads==
This information model is also available as [[Media:nl.zorg.Hypersensitivity-v1.0(2024EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.Hypersensitivity-v1.0(2024EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
The information in this wikipage is based on Prerelease 2024-1 
SNOMED CT and LOINC codes are based on:
<ul>
<li>SNOMED Clinical Terms versie: 20240331 [R] (maart 2024-editie)</li>
<li>LOINC version 2.77</li>
</ul>
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]] 
This page is generated on 25/04/2024 12:41:59 with ZibExtraction v. 9.3.8880.19756 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2024(EN)]] [[HCIM_Release_2024(EN) |Back to HCIM list ]]</div>

Hypersensitivity-v1.0(2024EN) - Bewerkingsoverzicht

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2024EN)}} ==General information== Name: '''nl.zorg.Hypersensitivity''' link=Overgevoeligheid-v1.0(2024NL) Version: '''1.0''' HCIM Status:Final Release: '''2024'''...'

Update bot: Nieuwe pagina aangemaakt met ' {{Versions-2.16.840.1.113883.2.4.3.11.60.40.3.8.4(EN)|1|Hypersensitivity-v1.0(2024EN)}} ==General information== Name: '''nl.zorg.Hypersensitivity''' link=Overgevoeligheid-v1.0(2024NL)
Version: '''1.0'''
HCIM Status:Final
Release: '''2024'''...'